Jung Eun Yim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jung Eun Yim has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Hyeong Mok Kwon
Department of Dermatology, Yeungnam University College of Medicine, Daegu, Korea
4 shared publications - Jong Soo Choi
Department of Dermatology, College of Medicine, Yeungnam University, Daegu, Korea
4 shared publications - Dong Hoon Shin
Department of Dermatology, Yeungnam University College of Medicine, Daegu, Korea
3 shared publications - Hye Ri Kim
Department of Dermatology, Yeungnam University College of Medicine, Daegu, Korea
3 shared publications - Young Kyung Bae
Department of Pathology, Yeungnam University College of Medicine, Daegu, Korea
3 shared publications - Eun Hye Jeong
Department of Dermatology Yeungnam University College of Medicine Daegu Korea
2 shared publications
Latest Publications
- Open Access
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 2) , S272-S274
Methotrexate-Induced Accelerated Nodulosis in a Patient with Systemic Lupus Erythematosus
Methotrexate (MTX)-induced accelerated nodulosis (MIAN) reportedly occurs in patients with rheumatic arthritis receiving MTX therapy. However, it has also been reported in patients with other autoinflammatory conditions, such as systemic lupus erythematosus (SLE). A 38-year-old woman diagnosed with SLE presented with multiple movable, firm, fleshcolored nodules on both hands that had developed 3 years ago. She was taking oral medications, specifically hydroxychloroquine, azathioprine, and MTX. Histopathological examination revealed palisaded granulomatous inflammation, surrounded by histiocytes and lymphocytes, along the dermis to the subcutaneous fat layer. Fibrinoid degeneration was observed at the center of the granulomatous inflammation, and dermal mucin deposition was not observed. The patient was diagnosed with MIAN, and therefore discontinuation of MTX was recommended. Subsequently, the lesions almost completely disappeared with no signs of recurrence. MIAN exhibits clinicopathological features similar to those of rheumatoid nodules; therefore, it can be easily misdiagnosed. Herein, we report a case of MIAN in a patient with SLE to contribute to the accurate diagnosis and appropriate management.
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 2) , S272-S274
Open AccessMethotrexate-Induced Accelerated Nodulosis in a Patient with Systemic Lupus Erythematosus
Methotrexate (MTX)-induced accelerated nodulosis (MIAN) reportedly occurs in patients with rheumatic arthritis receiving MTX therapy. However, it has also been reported in patients with other autoinflammatory conditions, such as systemic lupus erythematosus (SLE). A 38-year-old woman diagnosed with SLE presented with multiple movable, firm, fleshcolored nodules on both hands that had developed 3 years ago. She was taking oral medications, specifically hydroxychloroquine, azathioprine, and MTX. Histopathological examination revealed palisaded granulomatous inflammation, surrounded by histiocytes and lymphocytes, along the dermis to the subcutaneous fat layer. Fibrinoid degeneration was observed at the center of the granulomatous inflammation, and dermal mucin deposition was not observed. The patient was diagnosed with MIAN, and therefore discontinuation of MTX was recommended. Subsequently, the lesions almost completely disappeared with no signs of recurrence. MIAN exhibits clinicopathological features similar to those of rheumatoid nodules; therefore, it can be easily misdiagnosed. Herein, we report a case of MIAN in a patient with SLE to contribute to the accurate diagnosis and appropriate management.
- Open Access
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 1) , S25-S29
Superficial CD34-Positive Fibroblastic Tumor: Two Case Reports
Yim JE, et al. Ann Dermatol. 2023 May;35:e36. https://doi.org/10.5021/ad.20.328
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 1) , S25-S29
Open AccessSuperficial CD34-Positive Fibroblastic Tumor: Two Case Reports
Yim JE, et al. Ann Dermatol. 2023 May;35:e36. https://doi.org/10.5021/ad.20.328
- Open Access
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 1) , S10-S13
Intradermal Low-Fat Spindle Cell Lipoma: A Case Report
Kwon HM, et al. Ann Dermatol. 2023 May;35:e33. https://doi.org/10.5021/ad.21.051
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 1) , S10-S13
Open AccessIntradermal Low-Fat Spindle Cell Lipoma: A Case Report
Kwon HM, et al. Ann Dermatol. 2023 May;35:e33. https://doi.org/10.5021/ad.21.051
- Open Access
- 31 March 2022
- Published by Korean Society for Medical Mycology in Korean Journal of Medical Mycology
- p. 23-24
A Dermoscopic Finding of Tinea Capitis caused by Microsporum canis
Journal of mycology and infection (Acronym: JMI, Abbreviation: J Mycol Infect) aims to publish articles of exceptional interests in the field of medical mycology. The journal originally was launched in 1996 as the Korean Journal of Medical Mycology and has reformed into the current state beginning on March of 2018. The contents of the journal should elucidate important microbiological fundamentals and provide qualitative insights to respective clinical aspects. JMI underlines the submission of novel findings and studies in clinical mycology that are enriched by analyses achieved through investigative methods.
- 31 March 2022
- Published by Korean Society for Medical Mycology in Korean Journal of Medical Mycology
- p. 23-24
Open AccessA Dermoscopic Finding of Tinea Capitis caused by Microsporum canis
Journal of mycology and infection (Acronym: JMI, Abbreviation: J Mycol Infect) aims to publish articles of exceptional interests in the field of medical mycology. The journal originally was launched in 1996 as the Korean Journal of Medical Mycology and has reformed into the current state beginning on March of 2018. The contents of the journal should elucidate important microbiological fundamentals and provide qualitative insights to respective clinical aspects. JMI underlines the submission of novel findings and studies in clinical mycology that are enriched by analyses achieved through investigative methods.